Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Procedure Type & End-User The global transcatheter aortic valve replacement (TAVR) market will witness a robust CAGR of 13.1%, valued at $4.4 billion in 2021, expected to appreciate and reach $13.35 billion by 2030, confirms Strategic Market Research. Transcatheter aortic valve replacement is a surgical method that involves replacing a defective aortic valve without extracting it (aortic valve stenosis). A valve replacement usually necessitates an open-heart surgery with a sternotomy, in which the chest is surgically opened for the procedure. Still, the TAVI is performed through tiny holes, leaving all the chest bones in their situation. In addition, it includes implanting transcatheter aortic valves or transaortic valve implantation to restore the valve’s circulatory system capabilities. It is mainly performed to treat patients having aortic stenosis. These patients fall under the high-risk category where they cannot undertake SAVR procedures. The patients are mostly aged and are above 75 years. They are unable to have open-heart surgery because it is too dangerous for them. It is most beneficial for people who have limited options for repair. At present, FDA-approved the use of two TAVR systems for severe aortic stenosis in the United States: the balloon-expandableSapien XT valve (Edwards Lifesciences) and the self-expanding CoreValve (Medtronic, Inc.). In the world, cardiovascular diseases accounted for the highest number of deaths. In 2019, 17.9 million individuals died from CVDs worldwide, accounting for 32% of all deaths, whereas 85% occurred as a direct result of heart attacks and strokes. About three-quarters of deaths due to CVD occur in low- and middle-income countries. In addition, CVDs were responsible for 38% of the 17 million premature deaths (before the age of 70) caused by noncommunicable diseases in 2019. It is possible to prevent many cardiovascular diseases by controlling behavior risk factors such as cigarette smoking, poor diet, obesity, physical inactivity, and alcohol consumption. Impact of Covid 19 As the proportion of Covid-19 cases decreased over time, the number of surgeries had stepped up, enabling the related devices market of the transcatheter aortic valve implantation (TAVI) to recover. Despite the pandemic, the device manufacturers of the market in this sector continue to launch new products. For example, Boston Scientific stated on September 28th that the Accurate neo2 aortic valve system was now available in Europe. The ability of Boston Scientific to bring this device to European markets during the Covid-19 outbreak demonstrates the market’s robustness. Pre-pandemic, the number of TAVR surgeries was rapidly increasing, and this trend is unlikely to have slowed down because of the Covid-19. Market Drivers - The Prevalence of Cardiovascular Diseases Is on The Rise, And the Increasing Use of Less Invasive Medicines and An Aging Population Set to Drive the Market’s Growth The rise in the frequency of cardiovascular illnesses in the senior population improved surgical treatments, and the growing demand for surgical technologies are driving the transcatheter aortic valve replacement (TAVR) market. In addition, there has been a surge in terms of healthcare investment, which will aid the market’s expansion. These are the elements that have contributed to the market’s high growth rate throughout the predicted period. As a result, demand for the market is expected to rise globally. In addition, the market is being propelled by an increase in the acceptance rate of the TAVI treatments, new device approvals, and more clinical evidence of success. The primary factors which are driving the market’s growth are the increasing number of patients suffering from cardiovascular disease. Transcatheter aortic valve replacement ICD 10is caused by cardiovascular disorders, increasing demand for an effective valve replacement operation. Hence, the TAVR market trends are becoming more common due to the rising prevalence of aortic stenosis. The transcatheter aortic valve replacement market is growing because of the rising technical improvements, increased demand for minimally invasive catheter-based operations, as well as patients seeking an effective and efficient therapy with a speedy recovery. In addition, older people are more likely to have this procedure because open-heart surgery is exceptionally hazardous for them, and they cannot have a surgical aortic valve replacement (SAVR). Restraint - Stringent Government Regulations for Licensing Transcatheter and A Shortage of Experienced Specialists Will Stifle the Market’s Growth. TAVI market growth is hampered by stringent government regulations for licensing of transcatheter aortic valves, which are class III medical devices, and the high cost associated with TAVI. In addition, the high price of transcatheter heart valve devices in developing and underdeveloped nations has resulted in the inadequate installation of the heart valve in healthcare facilities. The Shortage of experienced specialists in some areas of emerging countries and a lack of awareness of the latest technical innovations among the individuals will restrain the market’s growth. Moreover, the market’s expansion is stifled by high costs and a lack of reimbursement. Opportunity - Rising Healthcare Expenditure in Emerging Economies TAVI systems have witnessed an upsurge due to the rising healthcare expenditure in emerging economies. According to the market analysis, The increasing interest from key players in the global industry provides the market with several growth opportunities over the projected timeframe. Market Analysis Of Different Segments Covered in the Report Based on Procedure Transfemoral Implantation Transapical Implantation Transaortic Implantation Based on End-User Hospitals Ambulatory Surgical centres Specialty Clinincs Regional Coverage Analysis North America U.S. Canada Mexico Europe Germany France Italy Switzerland U.K. Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA Procedure Analysis & Insights Transfemoral Implantation holds the largest market share, which as per the estimations, will increase due to variables such as the benefit of surgery, shorter recovery times, and lower hospitalization expenditures. The standardized TAVI procedure is transfemoral implantation, in which an artificial valve is inserted through the femoral artery with a bit use of anesthesia. Because of the ease of use and fewer complexities compared to other surgical procedures, transapical implantation is expected to be expanding most rapidly throughout the projection period. In addition, this treatment allows for a better route for devices of any diameter to enter the body, resulting in a longer tissue lifetime. End-User Analysis & Insights The hospitals accounted for the most significant market proportion, which is expected to rise at a CAGR of 4.8% throughout the anticipated period. A growing patient pool and a rising desire for efficient and effective treatment with shorter recovery times and shorter hospital stays hospitals will drive the global market share. After Hospitals, Ambulatory surgery centers are becoming more common for this procedure. Regional Analysis & Insights With more than 37.5 percent market share, Europe dominated the global TAVR market, followed by North America. As per estimations, the high occurrence of aortic stenosis and the availability of robust healthcare infrastructure, are two significant factors that will boost the market’s growth in Europe to develop over the projected period. In addition, the senior population’s high adoption rate of sophisticated transcatheter aortic valves will further contribute to the region’s growth. On the other hand, over the projected period, the market in the United States is predicted to rise due to an increase in the incidence of aortic stenosis and favorable reimbursement policies. However, during the forecasted period, Asia-Pacific is expected to increase faster due to rising senior populations in countries like Japan and China and advanced knowledge of TAVI heart valve replacement surgery among physicians and healthcare workers. In addition, the unexpected increase in the frequency of cardiovascular disorders and improved healthcare infrastructure would help this area develop and grow the TAVR market size. Transcatheter Aortic Valve Replacement Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 4.4 Billion The revenue forecast in 2030 USD 13.35 Billion Growth rate CAGR of approximately 13.01% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation The procedure, End-User, By Region. Procedure Transfemoral Implantation, Transapical Implantation, Transaortic Implantation. End-User Hospitals, Ambulatory Surgical centres, Specialty Clinics. By Region North America, Europe, Asia Pacific, Australian Bureau of Statistics. Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, St. Jude Medical, Inc., JenaValve Technology, Inc., Bracco SpA, Transcatheter Technologies GmbH, JC Medical, Inc., NVT AG. Pricing and purchase options Avail customized purchase options to meet your exact research needs. Transcatheter Aortic Valve Replacement Market Competitive Landscape Analysis Key Competitors mentioned in the TAVR Market are as follows: Medtronic plc Boston Scientific Corporation Edwards Lifesciences Corporation Abbott St. Jude Medical, Inc. JenaValve Technology, Inc. Bracco SpA Transcatheter Technologies GmbH JC Medical, Inc. NVT AG Recent Developments On August 2021, the Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis gained the approval of the FDA, as announced by Medtronic. It is designed to enhance the ease of use and provide greater precision and control throughout the procedure. On November 2020, Due to complexities with the product distribution system, Boston Scientific Corporation issued a global, voluntary recall of all unused inventory of the LOTUS EdgeTM Aortic Valve System. The voluntary recall is limited to the delivery system, while the valve works well and is clinically helpful after implantation. Frequently Asked Question About This Report What was the total TAVR market size in the year 2021? The market value of the market was $ 4.4 Billion in 2021. Who are the key companies/players in the TAVR market? Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, St. Jude Medical, JenaValve Technology, Bracco SpA, Transcatheter Technologies GmbH, JC Medical, NVT AG. Describe the factors driving the global market? The rise in the frequency of cardiovascular illnesses in the senior population improved surgical treatments, and the growing demand for surgery techniques are driving the overall market. Which segment accounted for the largest TAVR market share? Based on Procedure, Transfemoral implantation is the largest segment in the market. Based on Region, Europe dominated the entire market. How big will the Transcatheter Aortic Valve Replacement Market be? The global transcatheter aortic valve replacement market size was $4.4 Billion in 2021 and is predicted to reach $13.35 Billion by 2030, at a CAGR of 13.1% throughout the forecasted period of 2021-2030. What wil the total TAVR market size in the year 2030? The market value of the market will be $ 13.35 Billion in 2030. Sources https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) https://news.medtronic.com/2021-08-24-Medtronic-Announces-FDA-Approval-of-Next-Gen-TAVR-System-for-Treatment-of-Symptomatic-Severe-Aortic-Stenosis Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Global Market Segmentation 1.3.2 Geographic Scope Figure 02: Global Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Global Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Global Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Transcatheter Aortic Valve Replacement Market: Post-Covid-19 Figure 06: Impact of Covid-19 on the market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Global Market, 2021–2030 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Global Market, 2021–2030 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Global Market, 2021–2030(USD Million) 3.1.4 Market Summary Figure 10: Transfemoral Implantation to Witness Highest CAGR in Global Market, By Procedure, During Forecast Period Figure 11: Hospitals Higher CAGR in Global Market for End-User Segment during Forecast Period Figure 12: Europe to Account for Largest Share of Global Market In 2021 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 13: Global Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Market 5.2.1 Global market, 2021 – 2030 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global market, by region, 2021-2030 (USD Million) 5.4 Procedure Segment Analysis 5.4.1 Global market, By Procedure, 2021-2030 (USD Million) 5.5 End-User Segment Analysis 5.5.1 Global market, By End-User, 2021-2030 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 Global market PEST analysis 5.8.2 Global market Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 14 Global Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 15 Global Market Drivers and Their Impact 6.2.2 Restraints Figure 16 Global Market Restraints and Their Impact 6.2.3 Opportunities Figure 17 Global Market Opportunities and Their Impact 6.2.4 Challenges Figure 18 Global Market Challenges and Their Impact 6.3 Impact of Covid-19 on Global Market 6.4 Value Chain Analysis Figure 19 Value Chain Analysis: Global Market 6.5 Ecosystem Figure 20 Global Market: Ecosystem Table 3 Global Market: Ecosystem Figure 21 Revenue Shift in Global Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Global Market in the USA in Last 9 Years Figure 22 Top 12 Companies with Highest No. of Patents in Last 9 Years Figure 23 No of Patents Granted Per Year, 2019–2021 Table 5 List of Global Patents in the Global Market 6.7 Trade Analysis Figure 24 Import Data for Transfemoral Implantation, By Country, 2016–2021 (USD Thousand) Table 6 Import Data for Transcatheter Aortic Valve Replacement, By Country, 2016–2021 (USD Thousand) Table 7 Import Data for Transcatheter Aortic Valve Replacement, By Country, 2016–2021 (USD Thousand) Figure 25 Export Data for Transcatheter Aortic Valve Replacement, By Country, 2016–2021 (USD Thousand) Table 8 Export Data for Transcatheter Aortic Valve Replacement, By Country, 2016–2021 (USD Thousand) Table 9 Export Data for Transcatheter Aortic Valve Replacement, By Country, 2016–2021 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 10 Global Market: Porter’s Five Forces Analysis, 2021 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2021) 6.11.2 Trends in Technology (2021-2030) Table 11 Key Regulations: Global Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 12: Key Players market share Figure 26: Key players market share of companies 7.2 Manufacturers Global Manufacturing Sites, Area Served, Procedure 7.3 Global Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: Procedure Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2021-2030) Table 13 Global Market, By Procedure, 2021–2030 (USD Million) Figure 27 Global Market, By Procedure Figure 28 Transfemoral Implantation Segment to Register Highest CAGR in Global Market During Forecast Period 8.3 Transfemoral Implantation 8.3.1 Transfemoral Implantation market, 2021-2030 (USD Million) Figure 29: Transfemoral Implantation market, 2021-2030 (USD Million) 8.4 Transapical Implantation 8.4.1 Transapical Implantation market, 2021-2030 (USD Million) Figure 30: Transapical Implantation market, 2021-2030 (USD Million) 8.5 Transaortic Implantation 8.5.1 Transaortic Implantation market, 2021-2030 (USD Million) Figure 31: Transaortic Implantation market, 2021-2030 (USD Million) Chapter 9. Global Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2021-2030) Table 14: Global Market, By End-User, 2021–2030 (USD Million) Figure 31: Global Market, By End-User, 2021–2030 (USD Million) Figure 32: Hospitals Segment to Register Highest CAGR in Global Market during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2021-2030 (USD Million) Figure 33: Hospitals market, 2021-2030 (USD Million) 9.4 Ambulatory Surgical centers 9.4.1 Ambulatory Surgical centers market, 2021-2030 (USD Million) Figure 34: Ambulatory Surgical centers market, 2021-2030 (USD Million) 9.5 Specialty Clinics 9.5.1 Specialty Clinics market, 2021-2030 (USD Million) Figure 35: Specialty Clinics market, 2021-2030 (USD Million) Chapter 10. Global Market: Regional Outlook 10.1 North America Figure 37: North America Global Market, By Revenue Forecast (2021-2030) 10.1.1 North America Global market, by country, 2021-2030 (USD Million) Table 15: North America Global Market, by Country, 2021-2030 Figure 38: North America Global Market 10.1.2 North America Global market, By Procedure, 2021-2030 (USD Million) Table16: North America Global market, By Procedure, 2021-2030 (USD Million) Figure 39: North America Global market, By Procedure, 2021-2030 (USD Million) 10.1.3 North America Global market, by End-User, 2021-2030 (USD Million) Table 17: North America Global market, by End-User, 2021-2030 (USD Million) Figure 40: North America Global market, by End-User, 2021-2030 (USD Million) 10.1.4 U.S. 10.1.4.1 U.S. Global market, By Procedure, 2021-2030 (USD Million) Figure 41: U.S. Global market, By Procedure, 2021-2030 (USD Million) 10.1.4.2 U.S. Global market, by End-User, 2021-2030 (USD Million) Figure 42: U.S. Global market, by End-User, 2021-2030 (USD Million) 10.1.5 Canada 10.1.5.1 Canada Global market, By Procedure, 2021-2030 (USD Million) Figure 43: Canada Global market, By Procedure, 2021-2030 (USD Million) 10.1.5.2 Canada Global market, by End-User, 2021-2030 (USD Million) Figure 44: Canada Global market, by End-User, 2021-2030 (USD Million) Figure 45: Canada Global market, by End-User, 2021-2030 (USD Million) Figure 46: Canada Global market, by End-User, 2021-2030 (USD Million) 10.2 Europe Figure 47: Europe Global Market, By Revenue Forecast (2021-2030) 10.2.1 Europe Global market, by country, 2021-2030 (USD Million) Table 18: Europe Global market, by country, 2021-2030 (USD Million) Figure 48: Europe Global market, by country, 2021-2030 (USD Million) 10.2.2 Europe Global market, By Procedure, 2021-2030 (USD Million) Table 19: Europe Global market, By Procedure, 2021-2030 (USD Million) Figure 49: Europe Global market, By Procedure, 2021-2030 (USD Million) 10.2.3 Europe Global market, by End-User, 2021-2030 (USD Million) Table 20 : Europe Global market, by End-User, 2021-2030 (USD Million) Figure 50: Europe Global market, by End-User, 2021-2030 (USD Million) 10.2.4 U.K. 10.2.4.1 U.K. Global market, By Procedure, 2021-2030 (USD Million) Figure 51: U.K. Global market, By Procedure, 2021-2030 (USD Million) 10.2.4.2 U.K. Global market, by End-User, 2021-2030 (USD Million) Figure 52: U.K. Global market, by End-User, 2021-2030 (USD Million) 10.2.5 Germany 10.2.5.1 Germany Global market, By Procedure, 2021-2030 (USD Million) Figure 53: Germany Global market, By Procedure, 2021-2030 (USD Million) 10.2.5.2 Germany Global market, by End-User, 2021-2030 (USD Million) Figure 54: Germany Global market, by End-User, 2021-2030 (USD Million) 10.2.6 France 10.2.6.1 France Global market, By Procedure, 2021-2030 (USD Million) Figure 55: France Global market, By Procedure, 2021-2030 (USD Million) 10.2.6.2 France Global market, by End-User, 2021-2030 (USD Million) Figure 56: France Global market, by End-User, 2021-2030 (USD Million) 10.2.7 Rest of Europe 10.2.7.1 Rest of Europe Global market, By Procedure, 2021-2030 (USD Million) Figure 57: Rest of Europe Global market, By Procedure, 2021-2030 (USD Million) 10.2.7.2 Rest of Europe Global market, by End-User, 2021-2030 (USD Million) Figure 58: Rest of Europe Global market, by End-User, 2021-2030 (USD Million) 10.3 Asia Pacific Figure 59: Asia Pacific Global Market, By Revenue Forecast (2021-2030) 10.3.1 Asia Pacific Global market, by country, 2021-2030 (USD Million) Table 21: Asia Pacific Global market, by country, 2021-2030 (USD Million) Figure 60: Asia Pacific Global market, by country, 2021-2030 (USD Million) 10.3.2 Asia Pacific Global market, By Procedure, 2021-2030 (USD Million) Table 22: Asia Pacific Global market, By Procedure, 2021-2030 (USD Million) Figure 61: Asia Pacific Global market, By Procedure, 2021-2030 (USD Million) 10.3.3 Asia Pacific Global market, by End-User, 2021-2030 (USD Million) Table 23: Asia Pacific Global market, by End-User, 2021-2030 (USD Million) Figure 62: Asia Pacific Global market, by End-User, 2021-2030 (USD Million) 10.3.4 China 10.3.4.1 China Global market, By Procedure, 2021-2030 (USD Million) Figure 63: China Global market, By Procedure, 2021-2030 (USD Million) 10.3.4.2 China Global market, by End-User, 2021-2030 (USD Million) Figure 64: China Global market, by End-User, 2021-2030 (USD Million) 10.3.5 India 10.3.5.1 India Global market, By Procedure, 2021-2030 (USD Million) Figure 65: India Global market, By Procedure, 2021-2030 (USD Million) 10.3.5.2 India Global market, by End-User, 2021-2030 (USD Million) Figure 66: India Global market, by End-User, 2021-2030 (USD Million) 10.3.6 Japan 10.3.6.1 Japan Global market, By Procedure, 2021-2030 (USD Million) Figure 67: Japan Global market, By Procedure, 2021-2030 (USD Million) 10.3.6.2 Japan Global market, by End-User, 2021-2030 (USD Million) Figure 68: Japan Global market, by End-User, 2021-2030 (USD Million) 10.3.7 South Korea 10.3.7.1 South Korea Global market, By Procedure, 2021-2030 (USD Million) Figure 69: South Korea Global market, By Procedure, 2021-2030 (USD Million) 10.3.7.2 South Korea Global market, by End-User, 2021-2030 (USD Million) Figure 70: South Korea Global market, by End-User, 2021-2030 (USD Million) 10.3.8 Rest of APAC 10.3.8.1 Rest of APAC Global market, By Procedure, 2021-2030 (USD Million) Figure 71: Rest of APAC Global market, By Procedure, 2021-2030 (USD Million) 10.3.8.2 Rest of APAC Global market, by End-User, 2021-2030 (USD Million) Figure 72: Rest of APAC Global market, by End-User, 2021-2030 (USD Million) 10.4 Latin America Figure 73: Latin America Global Market, By Revenue Forecast (2021-2030) 10.4.1 Latin America Global market, by country, 2021-2030 (USD Million) Table 24: Latin America Global market, by country, 2021-2030 (USD Million) Figure 74: Latin America Global market, by country, 2021-2030 (USD Million) 10.4.2 Latin America Global market, By Procedure, 2021-2030 (USD Million) Table 25: Latin America Global market, By Procedure, 2021-2030 (USD Million) Figure 75: Latin America Global market, By Procedure, 2021-2030 (USD Million) 10.4.3 Latin America Global market, by End-User, 2021-2030 (USD Million) Table 26: Latin America Global market, by End-User, 2021-2030 (USD Million) Figure 76: Latin America Global market, by End-User, 2021-2030 (USD Million) 10.4.4 Brazil 10.4.4.1 Brazil Global market, By Procedure, 2021-2030 (USD Million) Figure 77: Brazil Global market, By Procedure, 2021-2030 (USD Million) 10.4.4.2 Brazil Global market, by End-User, 2021-2030 (USD Million) Figure 78: Brazil Global market, by End-User, 2021-2030 (USD Million) 10.4.5 Mexico 10.4.5.1 Mexico Global market, By Procedure, 2021-2030 (USD Million) Figure 79: Mexico Global market, By Procedure, 2021-2030 (USD Million) 10.4.5 2 Mexico Global market, by End-User, 2021-2030 (USD Million) Figure 80: Mexico Global market, by End-User, 2021-2030 (USD Million) 10.4.6 Rest of the Latin America 10.4.6.1 Rest of the Latin America Global market, By Procedure, 2021-2030 (USD Million) Figure 81: Rest of the Latin America Global market, By Procedure, 2021-2030 (USD Million) 10.4.6.2 Rest of the Latin America Global market, by End-User, 2021-2030 (USD Million) Figure 82: Rest of the Latin America Global market, by End-User, 2021-2030 (USD Million) 10.5 MEA Figure 83: MEA Global Market, By Revenue Forecast (2021-2030) 10.5.1 MEA Global market, By Procedure, 2021-2030 (USD Million) Figure 84: MEA Global market, By Procedure, 2021-2030 (USD Million) 10.5.2 MEA Global market, by End-User, 2021-2030 (USD Million) Figure 85: MEA Global market, by End-User, 2021-2030 (USD Million) Chapter 11. Competitive Landscape 11.1 Medtronic plc. 11.1.1 Company overview 11.1.2 Financial performance 11.1.3 Procedure Portfolio Analysis 11.1.4 Business Strategy & Recent Development 11.2 Boston Scientific Corporation. 11.2.1 Company overview 11.2.2 Financial performance 11.2.3 Procedure Portfolio Analysis 11.2.4 Business Strategy & Recent Development 11.3 Edwards Lifesciences Corporation. 11.3.1 Company overview 11.3.2 Financial performance 11.3.3 Procedure Portfolio Analysis 11.3.4 Business Strategy & Recent Development 11.4 Abbott. 11.4.1 Company overview 11.4.2 Financial performance 11.4.3 Procedure Portfolio Analysis 11.4.4 Business Strategy & Recent Development 11.5 St. Jude Medical, Inc. 11.5.1 Company overview 11.5.2 Financial performance 11.5.3 Procedure Portfolio Analysis 11.5.4 Business Strategy & Recent Development 11.6 F. JenaValve Technology, Inc. 11.6.1 Company overview 11.6.2 Financial performance 11.6.3 Procedure Portfolio Analysis 11.6.4 Business Strategy & Recent Development 11.7 Bracco SpA. 11.7.1 Company overview 11.7.2 Financial performance 11.7.3 Procedure Portfolio Analysis 11.7.4 Business Strategy & Recent Development 11.8 Transcatheter Technologies GmbH. 11.8.1 Company overview 11.8.2 Financial performance 11.8.3 Procedure Portfolio Analysis 11.8.4 Business Strategy & Recent Development 11.9 JC Medical, Inc. 11.9.1 Company overview 11.9.2 Financial performance 11.9.3 Procedure Portfolio Analysis 11.9.4 Business Strategy & Recent Development 11.10 NVT AG. 11.10.1 Company overview 11.10.2 Financial performance 11.10.3 Procedure Portfolio Analysis 11.10.4 Business Strategy & Recent Development